Riedl Khursigara Magdalena, Schlam Daniel, Noone Damien G, Bruno Valentina, Ortiz-Sandoval Carolina G, Pluthero Fred G, Kahr Walter H A, Bowman Mackenzie L, James Paula, Grinstein Sergio, Licht Christoph
Cell Biology Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Department of Pediatrics, Innsbruck Medical University, Innsbruck, Austria.
J Thromb Haemost. 2020 Jun;18(6):1484-1494. doi: 10.1111/jth.14767.
Defective complement inhibition can lead to the formation of membrane attack complexes (MAC; C5b-9) on the plasma membranes of vascular endothelial cells, resulting in injury that drives the progression of thrombotic microangiopathy (TMA), a key pathology in kidney disease.
OBJECTIVE/METHODS: We examined the response of human endothelial cells to complement-mediated damage using blood outgrowth endothelial cells (BOECs) derived from healthy donors. BOECs were sensitized to complement factors present in normal human serum to induce the formation of C5b-9 on their plasma membranes.
This triggered an expected abrupt rise in intracellular Ca reflecting membrane leakage. Remarkably, while intracellular Ca remained elevated, membrane leakage ceased within 30 minutes, and cells did not show significant death. Extensive mobilization of Weibel-Palade bodies (WPBs) was observed along with secretion of von Willebrand factor (VWF). The potential role of WPBs and VWF in mitigating complement-mediated damage was examined by comparing the effects of C5b-9 on BOECs derived from von Willebrand disease (VWD) patients expressing reduced amounts of VWF, lacking expression of functional VWF, or lacking both VWF and WPBs. BOECs lacking WPBs were not resistant to complement-mediated damage, but became resistant when transfected to express VWF (and thus WPBs).
We conclude that BOECs exposed to C5b-9 attack respond by mobilizing WPBs, which mitigate and repair damage by fusing with the plasma membrane. We propose that a similar cell-specific response may protect the vascular endothelium from complement-mediated damage in vivo.
补体抑制功能缺陷可导致血管内皮细胞质膜上形成膜攻击复合物(MAC;C5b - 9),从而造成损伤,推动血栓性微血管病(TMA)的进展,TMA是肾脏疾病的关键病理特征。
目的/方法:我们使用来自健康供体的血源内皮细胞(BOECs)研究了人内皮细胞对补体介导损伤的反应。使BOECs对正常人血清中存在的补体因子敏感,以诱导其质膜上形成C5b - 9。
这引发了细胞内钙的预期突然升高,反映了膜渗漏。值得注意的是,虽然细胞内钙持续升高,但膜渗漏在30分钟内停止,且细胞未显示出明显死亡。观察到Weibel - Palade小体(WPBs)大量动员,同时伴有血管性血友病因子(VWF)的分泌。通过比较C5b - 9对来自血管性血友病(VWD)患者的BOECs的影响,研究了WPBs和VWF在减轻补体介导损伤中的潜在作用,这些患者表达的VWF量减少、缺乏功能性VWF表达或同时缺乏VWF和WPBs。缺乏WPBs的BOECs对补体介导的损伤没有抗性,但转染表达VWF(从而表达WPBs)后则具有抗性。
我们得出结论,暴露于C5b - 9攻击的BOECs通过动员WPBs做出反应,WPBs通过与质膜融合来减轻和修复损伤。我们提出,类似的细胞特异性反应可能在体内保护血管内皮免受补体介导的损伤。